- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Case Reports in Medicine
Volume 2012 (2012), Article ID 503956, 3 pages
A Case of Acute Prosthesis Migration after Femoral Head Replacement due to Osteomalacia by FGF23-Induced Tumor
Department of Orthopaedic Surgery, Graduate School of Medicine, Kobe University, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
Received 26 September 2012; Accepted 30 October 2012
Academic Editor: Jeffrey C. Wang
Copyright © 2012 Shinya Hayashi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- K. E. White, W. E. Evans, J. L. H. O'Riordan et al., “Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23,” Nature Genetics, vol. 26, no. 3, pp. 345–348, 2000.
- T. Shimada, S. Mizutani, T. Muto et al., “Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 11, pp. 6500–6505, 2001.
- T. Shimada, M. Kakitani, Y. Yamazaki et al., “Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism,” Journal of Clinical Investigation, vol. 113, no. 4, pp. 561–568, 2004.
- A. J. Reginato, G. F. Falasca, R. Pappu, B. McKnight, and A. Agha, “Musculoskeletal manifestations of osteomalacia: report of 26 cases and literature review,” Seminars in Arthritis and Rheumatism, vol. 28, no. 5, pp. 287–304, 1999.
- A. J. Reginato and J. A. Coquia, “Musculoskeletal manifestations of osteomalacia and rickets,” Best Practice and Research, vol. 17, no. 6, pp. 1063–1080, 2003.
- T. Shimada, H. Hasegawa, Y. Yamazaki et al., “FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis,” Journal of Bone and Mineral Research, vol. 19, no. 3, pp. 429–435, 2004.
- I. Stewart, C. Roddie, A. Gill et al., “Elevated serum FGF23 concentrations in plasma cell dyscrasias,” Bone, vol. 39, no. 2, pp. 369–376, 2006.
- M. B. Zimering, F. A. Caldarella, K. E. White, and M. J. Econs, “Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes,” Endocrine Practice, vol. 11, no. 2, pp. 108–114, 2005.
- F. M. F. Cheung, L. Ma, W. C. Wu, T. H. Siu, P. T. Choi, and Y. P. Tai, “Oncogenic osteomalacia associated with an occult phosphaturic mesenchymal tumour: clinico-radiologico-pathological correlation and ultrastructural studies,” Hong Kong Medical Journal, vol. 12, no. 4, pp. 319–321, 2006.